Beta Nerve Growth Factor (β-NGF) is one of the most important neurotrophic factors in the human body. It plays a critical role in the development, maintenance, and survival of neurons, helping nerve cells grow, communicate, and respond to injury.
NGF is particularly important for cholinergic neurons, a group of nerve cells involved in learning, memory, and cognitive function. These neurons are known to be affected in Alzheimer's disease and other neurodegenerative conditions, making NGF an important area of neurological research.
The Beta Nerve Growth Factor marker in the Alzheimer's LINX™ panel does not measure circulating NGF concentrations. Instead, it evaluates whether the immune system has developed antibodies against β-NGF. Elevated immune reactivity may suggest that the immune system is recognizing this neurotrophic protein as a target.
Researchers continue to investigate how immune dysregulation, chronic inflammation, blood-brain barrier dysfunction, and neurodegenerative processes may interact. Immune reactivity to β-NGF may represent one component of a broader pattern of neurological immune responses that can be evaluated through the Alzheimer's LINX™ panel.
A positive result does not indicate Alzheimer's disease, dementia, or loss of cognitive function. Likewise, a normal result does not exclude neurological disease. Results should be interpreted in the context of other Alzheimer's LINX™ biomarkers, clinical symptoms, cognitive assessments, and established neurological testing.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.